Primary Neuroendocrine Tumor in a Horseshoe Kidney With Positive 111In-Pentetreotide Somatostatin Receptor Scintigraphy and Negative 18F-DOPA PET/CT

Clin Nucl Med. 2015 Nov;40(11):e516-7. doi: 10.1097/RLU.0000000000000911.

Abstract

Primary renal neuroendocrine tumors (NETs) are low-grade tumors with neuroendocrine differentiation and have been reported to arise most commonly in renal abnormalities such as horseshoe kidney. We report a case of a 54-year-old woman with history of invasive ductal breast carcinoma presenting several liver lesions. Histological findings finally revealed liver locations of a well-differentiated NET. Imaging workup combining somatostatin receptor scintigraphy and F-DOPA PET/CT finally enable proper diagnosis of primary renal NET located on the isthmus of a horseshoe kidney.

Publication types

  • Case Reports

MeSH terms

  • Dihydroxyphenylalanine / analogs & derivatives*
  • Female
  • Fused Kidney / diagnostic imaging*
  • Humans
  • Middle Aged
  • Multimodal Imaging
  • Neuroendocrine Tumors / diagnostic imaging*
  • Positron-Emission Tomography*
  • Radiopharmaceuticals*
  • Somatostatin / analogs & derivatives*
  • Tomography, X-Ray Computed*

Substances

  • Radiopharmaceuticals
  • 5-fluorodopa
  • Somatostatin
  • Dihydroxyphenylalanine
  • pentetreotide